Inari
Analise Reeves serves as the Platform Lead at Inari since May 2024, with extensive experience in synthetic biology. Previously, Analise held various leadership positions at Synlogic from October 2020 to May 2024, including Director, Head of Synthetic Biology, where responsibilities encompassed managing a synthetic biology project portfolio, providing scientific expertise, and contributing to business development. Other notable roles at Synlogic included Director, Head of Synthetic Biology Discovery, and Head of Synthetic Biology Operations, showcasing a strong focus on operational efficiency and team mentorship. Prior experience includes a position as a Senior Scientist at Senda Biosciences, as well as roles at Bayer Crop Science and Monsanto Company. Early career research was conducted at Massachusetts General Hospital and Harvard Medical School, culminating in a PhD in Microbiology and Molecular Genetics from Emory University.
Inari
4 followers
Founded by Flagship Pioneering in 2016, Inari partners with independent seed producers, using predictive design and a unique genetic toolbox to introduce high performing plant varieties that improve the economic and environmental realities of production agriculture. Headquartered in Cambridge, Massachusetts, with additional sites in West Lafayette, Indiana, and Ghent, Belgium, Inari has a growing team of more than 160 employees.